Morphin 10 Retard (Morphine Sulfate)

Morphine sulfate acts as a mu‑opioid receptor agonist in the central nervous system. By binding these receptors, it blocks transmission of pain signals, alters pain perception, and produces analgesia, sedation, and reduced autonomic responses.

The specific dose of Morphin 10 Retard is determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, renal and hepatic function, and individual response. Dosage adjustments are made under medical supervision.

Safety of morphine sulfate in pregnancy or lactation has not been definitively established. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant. Clinicians should assess risks and discuss alternatives with the patient.

To order Morphin 10 Retard, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Morphin 10 Retard provides extended‑release delivery of morphine sulfate, offering steadier plasma concentrations over 12‑24 hours compared with immediate‑release formulations. This can reduce dosing frequency and improve pain control for chronic severe pain, whereas short‑acting opioids may require multiple daily doses.

Store Morphin 10 Retard tablets at ambient temperature, below 25 °C, in the original container. Protect from moisture, direct sunlight and excessive heat to maintain tablet integrity and potency.

Morphin 10 Retard is taken orally, usually whole with water. The tablet should not be crushed, chewed, or broken, as this can release the entire dose at once and increase the risk of serious adverse effects.

The most serious risks include respiratory depression, severe hypotension, and allergic reactions such as anaphylaxis. Patients should be monitored closely for signs of these events, especially during dose initiation or when combined with other depressant drugs.

Morphin 10 Retard is contraindicated in patients with known hypersensitivity to morphine or other opioids, those who have experienced severe respiratory depression, acute or severe bronchial asthma, or paralytic ileus. It should also be avoided in individuals taking MAO inhibitors within the past 14 days.